Fate Therapeutics, Inc. FATE
2.01 USD -0.07 -3.37%
At close · Nov 2
2.02 +0.01 +0.27%
After hours · Nov 2, 4:48 PM ET
- YTD
- +105.10%
- 1 year
- +48.89%
- Open
- 2.09
- Prev close
- 2.08
- Mkt cap
- 240.84M
- Vol
- 1.27M
- Avg vol
- 1.58M
- EPS
- -1.01
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.98
- High
- 2.15
- Forward P/E
- -0.99
- Beta
- 1.88
- Short ratio
- 3.10
- Inst. own
- 102.25%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.53
- 200-d avg
- 3.93
- 1y target
- 6.31
5D chart
Chart tools
Chart is warming up
The five-day price history for FATE has not been loaded yet. Try again in a moment.
Altman Z-Score
-8.27 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 3
P/E -0.9×
P/S 17.6×
P/B 0.6×
P/FCF -1.0×
EV/EBITDA -1.2×
EV/Sales 22.3×
FCF Yield -96.0%
Gross Margin -94.1%
Operating Margin -2222.4%
Net Margin -2051.1%
ROE -65.8%
ROIC -51.4%
ROA -42.7%
Revenue -51.2%
Operating Income 29.8%
EPS (diluted) 29.9%
Free Cash Flow 9.4%
Current Ratio 5.8×
Quick Ratio 5.8×
Debt / Equity 0.4×
Net Debt / EBITDA -0.2×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31